PPARα governs glycerol metabolism

Journal of Clinical Investigation

Volumn 114, Issue 1, 2004, Pages 94-103

  Patsouris, David ^a   Mandard, Stéphane ^a   Voshol, Peter J ^b   Escher, Pascal ^c   Tan, Nguan Soon ^d   Havekes, Louis M ^b   Koenig, Wolfgang ^e   März, Winfried ^f   Tafuri, Sherrie ^c   Wahli, Walter ^d   Müller, Michael ^a   Kersten, Sander ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c PFIZER INC   (United States)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

^e UNIVERSITY OF ULM   (Germany)

^f UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 3; AQUAPORIN 9; CIGLITAZONE; FENOFIBRATE; GLYCEROL; GLYCEROL 3 PHOSPHATE DEHYDROGENASE; GLYCEROL KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PIRINIXIC ACID; ROSIGLITAZONE; CELL RECEPTOR; PRIMER DNA; RECOMBINANT PROTEIN; TRANSCRIPTION FACTOR;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENOTYPE; GLUCONEOGENESIS; GLYCEROL BLOOD LEVEL; IMMUNOPRECIPITATION; LIPOLYSIS; LIVER MITOCHONDRION; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TRANSACTIVATION; WILD TYPE; ANIMAL; CELL STRAIN 3T3; DNA MICROARRAY; GENETIC TRANSFECTION; GENETICS; HOMEOSTASIS; HUMAN; LIVER; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; MOLECULAR CLONING; MOUSE MUTANT; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PLASMID; TUMOR CELL LINE;

3T3 CELLS; ANIMALS; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CLONING, MOLECULAR; DNA PRIMERS; GENE EXPRESSION REGULATION; GLYCEROL; HOMEOSTASIS; HUMANS; LIVER; LIVER NEOPLASMS; MICE; MICE, KNOCKOUT; MODELS, ANIMAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLASMIDS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECOMBINANT PROTEINS; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 3242750659     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200420468     Document Type: Article

References (47)

1. Bergman, R.N. and Ader, M. 2000. Free fatty acids and pathogenesis of type 2 diabetes mellicus. Trends Endocrinol. Metab. 11:351-356.
2. Chen, X., Iqbal, N., and Boden, G. 1999. The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects. J. Clin. Invest. 103:365-372.
3. Gonzalez-Manchon, C., Martin-Requero, A., Ayuso, M.S., and Parrilla, R. 1992. Role of endogenous fatty acids in the control of hepatic gluconeogenesis. Arch. Biochem. Biophys. 292:95-101.
4. Lam, T.K., et al. 2003. Mechanisms of the free fatty acid-induced increase in hepatic glucose production. Am. J. Physiol. Endocrinol. Metab. 284:E863-E873.
5. Rebrin, K., Steil, G.M., Getty, L., and Bergman, R.N. 1995. Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes. 44:1038-1045.
6. Roden, M., et al. 2000. Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans. Diabetes. 49:701-707.
7. Kersten, S., Desvergne, B., and Wahli, W. 2000. Roles of PPARs in health and disease. Nature. 405:421-424.
8. Rosen, E.D., and Spiegelman, B.M. 2000. Molecular regulation of adipogenesis. Annu. Rev. Cell Dev. Biol. 16:145-171.
9. Di Poi, N., Tan, N.S., Michalik, L., Wahli, W., and Desvergne, B. 2002. Antiapoptotic role of PPAR-beta in keratinocytes via transcriptional control of the Akt1 signaling pathway. Mol. Cell. 10:721-733.
10. Leibowitz, M.D., et al. 2000. Activation of PPARdelta alters lipid metabolism in db/db mice. FEBS Lett. 473:333-336.
11. Wang, Y.X., et al. 2003. Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell. 113:159-170.
12. Hashimoto, T., et al. 2000. Defect in peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation determines of the severity of hepatic steatosis in response to fasting. J. Biol. Chem. 275:28918-28928.
13. Kersten, S., et al. 1999. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J. Clin. Invest. 103:1489-1498.
14. Leone, T.C., Weinheimer, C.J., and Kelly, D.P. 1999. A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. Proc. Natl. Acad. Sci. U. S. A. 96:7473-7478.
15. Carbrey, J.M., et al. 2003. Aquaglyceroporin AQP9: solute permeation and metabolic control of expression in liver. Proc. Natl. Acad. Sci. U. S. A. 100:2945-2950.
16. Guan, H.P., et al. 2002. A futile metabolic cycle activated in adipocytes by antidiabetic agents. Nat. Med. 8:1122-1128.
17. Picard, F. and Auwerx, J. 2002. PPAR(gamma) and glucose homeostasis. Annu. Rev. Nutr. 22:167-197.
18. Guerre-Millo, M., et al. 2001. PPAR-alpha-null mice are protected from high-fat diet-induced insulin resistance. Diabetes. 50:2809-2814.
19. Tordjman, K., et al. 2001. PPARalpha deficiency reduces insulin resistance and atherosclerosis in apoE-null mice. J. Clin. Invest. 107:1025-1034.
20. Lee, H.J., et al. 2002. Fenofibrate lowers abdominal and skeletal adiposity and improves insulin sensitivity in OLETF rats. Biochem. Biophys. Res. Common. 296:293-299.
21. Chou, C.J., et al. 2002. WY14,643, a peroxisome proliferator-activated receptor alpha (PPARalpha) agonist, improves hepatic and muscle steatosis and reverses insulin resistance in lipoatrophic A-ZIP/F-J mice. J. Biol. Chem. 277:24484-24489.
22. Kim, H., et al. 2003. Peroxisome proliferator-activated receptor-alpha agonist treatment in a transgenic model of type 2 diabetes reverses the lipotoxic state and improves glucose homeostasis. Diabetes. 52:1770-1778.
23. Koh, E.H., et al. 2003. Peroxisome proliferator-activated receptor (PPAR)-alpha activation prevents diabetes in OLETF rats: comparison with PPAR-gamma activation. Diabetes. 52:2331-2337.
24. Ye, J.M., et al. 2001. Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: comparison with PPAR-gamma activation. Diabetes. 50:411-417.
25. Bernal-Mizrachi, C., et al. 2003. Dexamethasone induction of hypertension and diabetes is PPAR-alpha dependent in LDL receptor-null mice. Nat. Med. 9:1069-1075.
26. Larsen, P.J., et al. 2003. Differential influences of peroxisome proliferator-activated receptors gamma and -alpha on food intake and energy homeostasis. Diabetes. 52:2249-2259.
27. Rizvi, F., et al. 2003. Antidyslipidemic action of fenofibrate in dyslipidemic-diabetic hamster model. Biochem. Biophys. Res. Commun. 305:215-222.
28. Baba, H., Zhang, X.J., and Wolfe, R.R. 1995. Glycerol gluconeogenesis in fasting humans. Nutrition. 11:149-153.
29. Peroni, O., Large, V., and Beylot, M. 1995. Measuring gluconeogenesis with [2-13C] glycerol and mass isotopomer distribution analysis of glucose. Am. J. Physiol. 269:E516-E523.
30. Sjarif, D.R., Ploos van Amstel, J.K., Duran, M., Beemer, F.A., and Poll-The, B.T. 2000. Isolated and contiguous glycerol kinase gene disorders: a review. J. Inherit. Metab. Dis. 23:529-547.
31. Brown, L.J., Koza, R.A., Marshall, L., Kozak, L.P., and MacDonald, M.J. 2002. Lechal hypoglycemic ketosis and glyceroluria in mice lacking both the mitochondrial and the cytosolic glycerol phosphate dehydrogenases. J. Biol. Chem. 277:32899-32904.
32. Tordjman, J., et al. 2003. Regulation of glyceroneogenesis and phosphoenolpyruvate carboxykinase by fatty acids, retinoic acids and thiazolidinediones: potential relevance to type 2 diabetes. Biochimie. 85:1213-1218.
33. Kersten, S., et al. 2001. The peroxisome proliferator-activated receptor alpha regulates amino acid metabolism. FASEB J. 15:1971-1978.
34. Haluzik, M., Gavrilova, O., and LeRoith, D. 2004. Peroxisome proliferator-activated receptor-alpha deficiency does not alter insulin sensitivity in mice maintained on regular or high-fat diet: hyperinsulinemic- euglycemic clamp studies. Endocrinology. 145:1662-1667.
35. Yamauchi, T., et al. 2001. The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance. J. Biol. Chem. 276:41245-41254.
36. Xu, J., et al. 2002. Peroxisome proliferator-activated receptor alpha (PPARalpha) influences substrate utilization for hepatic glucose production. J. Biol. Chem. 277:50237-50244.
37. Muoio, D.M., et al. 2002. Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) alpha knock-out mice. Evidence for compensatory regulation by PPAR delta. J. Biol. Chem. 277:26089-26097.
38. Bandsma, R.H., et al. 2004. Hepatic de novo synthesis of glucose 6-phosphate is not affected in peroxisome proliferator-activated receptor alpha-deficient mice but is preferentially directed toward hepatic glycogen stores after a short term fast. J. Biol. Chem. 279:8930-8937.
39. Kishida, K., et al. 2001. Enhancement of the aquaporin adipose gene expression by a peroxisome proliferator-activated receptor gamma. J. Biol. Chem. 276:48572-48579.
40. Croniger, C., Leahy, P., Reshef, L., and Hanson, R.W. 1998. C/EBP and the control of phosphoenolpyruvate carboxykinase gene transcription in the liver. J. Biol. Chem. 273:31629-31632.
41. Rhee, J., et al. 2003. Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis. Proc. Natl. Acad. Sci. U. S. A. 100:4012-4017.
42. Voshol, P.J. et al. 2003. Increased hepatic insulin sensitivity together with decreased hepatic triglyceride stores in hormone-sensitive lipase-deficient mice. Endocrinology. 144:3456-3462.
43. Wabitsch, M., et al. 2001. Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation. Int. J. Obes. Relat. Metab. Disord. 25:8-15.
44. Wise, L.S., and Green, H. 1979. Participation of one isozyme of cytosolic glycerophosphate dehydrogenase in the adipose conversion of 3T3 cells. J. Biol. Chem. 254:273-275.
45. Leclercq, P., et al. 1997. Inhibition of glycerol metabolism in hepatocytes isolated from endotoxic rats. Biochem. J. 325:519-525.
46. Kersten, S., et al. 2000. Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene. J. Biol. Chem. 275:28488-28493.
47. Upenberg, A., Jeannin, E., Wahli, W., and Desvergne, B. 1997. Polarity and specific sequence requirements of peroxisome proliferator-activated receptor (PPAR)/retinoid X receptor heterodimer binding to DNA. A functional analysis of the malic enzyme gene PPAR response element. J. Biol. Chem. 272:20108-20117.